Fny Investment Advisers, LLC Quotient LTD Transaction History

Fny Investment Advisers, LLC

$194 Million
Q4 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 25, 2022	SELL	$0.94 - $2.38 $3,238 - $8,199	-3,445 Reduced 94.51%	200 $0
Q3 2021 Oct 13, 2021	SELL	$2.34 - $3.77 $7,020 - $11,310	-3,000 Reduced 45.15%	3,645 $8,000
Q2 2021 Jul 14, 2021	SELL	$3.48 - $4.45 $31,320 - $40,050	-9,000 Reduced 57.53%	6,645 $24,000
Q1 2021 Apr 12, 2021	SELL	$3.57 - $6.2 $181,909 - $315,921	-50,955 Reduced 76.51%	15,645 $57,000
Q4 2020 Jan 19, 2021	BUY	$4.4 - $7.32 $175,560 - $292,068	39,900 Added 149.44%	66,600 $346,000
Q3 2020 Oct 09, 2020	BUY	$4.38 - $8.35 $19,710 - $37,575	4,500 Added 20.27%	26,700 $137,000
Q2 2020 Jul 10, 2020	SELL	$3.64 - $9.26 $78,624 - $200,016	-21,600 Reduced 49.32%	22,200 $164,000
Q1 2020 Apr 09, 2020	BUY	$2.54 - $9.38 $68,072 - $251,384	26,800 Added 157.65%	43,800 $173,000
Q4 2019 Jan 10, 2020	SELL	$7.07 - $9.51 $29,736 - $39,999	-4,206 Reduced 19.83%	17,000 $161,000
Q3 2019 Oct 25, 2019	BUY	$7.77 - $11.26 $2,618 - $3,794	337 Added 1.61%	21,206 $164,000
Q2 2019 Jul 24, 2019	BUY	$7.91 - $10.25 $165,073 - $213,907	20,869 New	20,869 $195,000
Q1 2019 Apr 17, 2019	SELL	$6.0 - $11.07 $47,400 - $87,453	-7,900 Closed	0 $0
Q4 2018 Jan 22, 2019	SELL	$5.81 - $7.89 $221,360 - $300,609	-38,100 Reduced 82.83%	7,900 $48,000
Q3 2018 Oct 29, 2018	SELL	$6.57 - $8.31 $265,428 - $335,724	-40,400 Reduced 46.76%	46,000 $346,000
Q2 2018 Jul 18, 2018	BUY	$3.93 - $8.93 $339,552 - $771,552	86,400 New	86,400 $693,000

Others Institutions Holding QTNT

# of Institutions

1

Shares Held

1.71K

Call Options Held

0

Put Options Held

0

Brewin Dolphin LTD London, X0

1.71K
Shares

$68
0.0% of portfolio

About Quotient Ltd

Ticker QTNT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Description
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...

More about QTNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.